Blog

22 Articles

DNA aqua pipette
Research
February 26, 2020 • 6 Min

Exploiting DNA Mutations For Pancreatic Cancer Treatment

Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.

Julie Sutcliffe in her lab
Research
October 4, 2019 • 5 Min

Harnessing the Power of Radionuclide Therapy

Julie Sutcliffe is working with targeted radionuclide therapy to go after pancreatic cancer cells that have spread beyond the pancreas.

Old medicine bottles
Research
January 22, 2019 • 4 Min

A PARP Inhibitor Approval for Pancreatic Cancer

PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.

Dr. Allyson Ocean
Research
January 9, 2019 • 6 Min

Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019

Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.

Draining board
Research
July 5, 2018 • 4 Min

A Potential Role for PARP Inhibitors in Pancreatic Cancer

Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.

Dr. Margaret Tempero
Research
June 23, 2017 • 4 Min

Targeted Therapy for Pancreatic Cancer

Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.

Cancer Moonshot meeting with Vice President Joe Biden and President Barack Obama
Research
December 30, 2016 • 4 Min

The Cancer Moonshot

Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.

  • 1
  • 2